Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

The Path to Next Generation Cancer Therapeutics: A Structure Guided Approach

FY 2019-20

Summary
"Cancer is characterized by the uncontrolled growth of cells. Normally, cells know when to grow, divide, and stop growing. To know when to start growing, cells rely on certain proteins that act as a switch. This switch recognizes signals in the body and turns ""on"" when the cell needs to start growing to prepare to multiply. A key protein in this switch is called BRAF. BRAF is mutated in many cancers, causing this cellular ""switch"" to stay on, resulting in uncontrolled growth. There are drugs that can deactivate mutated BRAF in cancer cells, preventing it from keeping the cell growth switch on. Strangely, these same drugs cause the opposite effect in normal cells; they activate normal BRAF, which activates the switch which can promote the growth of new cancers. This adverse process is poorly understood, therefore the use of these drugs to treat cancer patients have been limited. The aim of my research is to develop safer and more effective drugs that target BRAF and the cell growth switch, specifically in cancer cells, without having any effects on normal cells. I believe I can achieve this goal by: a) Explaining why this adverse effect is happening in normal cells. b) Understanding the differences in the configuration of the ""switch"" when BRAF is on vs when it is off. With this information, I will be able to design revolutionary drugs to freeze the BRAF protein in its off position within the switch system. I plan to achieve this by using a technique called cryo-electron microscopy which will allow me to view interactions within the switch and drugs at an atomic level. When completed, these drugs will be able to effectively turn the growth switch off, putting a stop to the growth of cancer cells, resulting in a safer, more effective treatment for cancer patients. "
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
428959
Name
Mannar Dhiraj
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Path to Next Generation Cancer Therapeutics: A Structure Guided Approach
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biochemistry; Cancer; Chemotherapy; Cryo-Electron Microscopy; Kinase Inhibition; Melanoma; Signal Transduction; Structural Biology; Structure Based Drug Design; Translational Research
Abstract
"Cancer is characterized by the uncontrolled growth of cells. Normally, cells know when to grow, divide, and stop growing. To know when to start growing, cells rely on certain proteins that act as a switch. This switch recognizes signals in the body and turns ""on"" when the cell needs to start growing to prepare to multiply. A key protein in this switch is called BRAF. BRAF is mutated in many cancers, causing this cellular ""switch"" to stay on, resulting in uncontrolled growth. There are drugs that can deactivate mutated BRAF in cancer cells, preventing it from keeping the cell growth switch on. Strangely, these same drugs cause the opposite effect in normal cells; they <em>activate</em> normal BRAF, which activates the switch which can promote the growth of new cancers. This adverse process is poorly understood, therefore the use of these drugs to treat cancer patients have been limited. The aim of my research is to develop safer and more effective drugs that target BRAF and the cell growth switch, specifically in cancer cells, without having any effects on normal cells. I believe I can achieve this goal by: a) Explaining why this adverse effect is happening in normal cells. b) Understanding the differences in the configuration of the ""switch"" when BRAF is on vs when it is off. With this information, I will be able to design revolutionary drugs to freeze the BRAF protein in its off position within the switch system. I plan to achieve this by using a technique called <em>cryo-electron microscopy</em> which will allow me to view interactions within the switch and drugs at an atomic level. When completed, these drugs will be able to effectively turn the growth switch off, putting a stop to the growth of cancer cells, resulting in a safer, more effective treatment for cancer patients. "
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mannar, Dhiraj
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~